Corcept Therapeutics
2 known investors
Corcept develops novel therapeutics targeting cortisol modulation through the glucocorticoid receptor to treat serious diseases across endocrinology, oncology, metabolism, and neurology. The company conducts over 30 clinical studies to establish the scientific foundation for new treatment approaches.